Clinical Trial Update: Safety and Effectiveness of OCL 503 in the Treatment of Women With Leiomyomata [NA]

View source ↗

Summary

Clinical trial update for OCL 503 assessing safety and effectiveness in women with leiomyomata (fibroids); study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyomata of Uterus

Drugs mentioned

• OCL 503

Snippet

Sponsor: IMBiotechnologies Ltd. | Conditions: Leiomyomata | NA | Status: COMPLETED | Results posted: 2018-09-07